Ocugen (OCGN) Corporate Presentation from NobleCon18Research, News and Market Data on OcugenNobleCon 18 Complete Rebroadcast
|
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌
1/22/2025
Media and Entertainment
Release – Lucky Strike Entertainment to Report Second Quarter 2025 Financial Results on February 5, 2025
Lucky Strike Entertainment (NYSE: LUCK), one of the world’s premier operators of location-based entertainment, will report financial results for the second quarter of fiscal 2025 on Wednesday, February 5, 2025,...
2 min read
‌
1/22/2025
Natural Resources
Release – Maple Gold Commences 10,000 Metre Phase I Drill Program at Douay and Provides 2025 Outlook for the Douay/Joutel Gold Project
Maple Gold Mines Ltd. (TSXV: MGM) (OTCQB: MGMLF) (FSE: M3G)Â (“Maple Gold” or the “Company”) is pleased to provide an exploration update and 2025 outlook for its 100%-owned Douay Gold Project...
13 min read
‌
1/22/2025
Tech
Nvidia and Tech Stocks Rally After Trump’s $500 Billion Stargate AI Announcement
Nvidia stock surged by more than 4% on Wednesday, marking a significant leap following President Donald Trump’s announcement of the massive $500 billion Stargate AI initiative. The project, set to...
3 min read
‌
1/22/2025
Health
Nutriband (NTRB) – Initiating Coverage With An Outperform Rating And $13 Price Target
We Are Initiating Coverage With An Outperform Rating. Nutriband, Inc. is a pharmaceutical company developing transdermal patch technologies for drug delivery. Its proprietary technology, known as AVERSA, has abuse-deterrent features with...
2 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.